Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2023 - 2026)
Ascentage Pharma Group International (AAPG) posted quarterly Goodwill & Intangibles of $12.8 million for Q4 2025, down 8.84% year-over-year from $14.0 million in Q4 2024, and down 4.33% quarter-over-quarter from $13.4 million in Q2 2025.
Analysis
Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2023 - 2026) Analysis & Trends
Ascentage Pharma Group International's Goodwill & Intangibles history runs 4 years deep, the most recent figure standing at $12.8 million for Q4 2025.
- In Q4 2025, Goodwill & Intangibles fell 8.84% year-over-year to $12.8 million; the TTM figure through Dec 2025 stood at $12.8 million (down 8.84% YoY), while the FY2025 annual figure was $12.6 million, down 10.03% from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $12.8 million, down from $13.4 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $14.0 million in Q4 2024, with the low at $4.0 million in Q4 2022.
- The 4-year median for Goodwill & Intangibles is $12.8 million (2025), against an average of $10.3 million.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles surged 94.77% in 2024, then declined 8.84% in 2025.
- Ascentage Pharma Group International's Goodwill & Intangibles stood at $4.0 million in 2022, then surged by 78.82% to $7.2 million in 2023, then jumped by 94.77% to $14.0 million in 2024, then dropped by 8.84% to $12.8 million in 2025.
- Business Quant data shows AAPG's Goodwill & Intangibles at $12.8 million in Q4 2025, $13.4 million in Q2 2025, and $14.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ascentage Pharma Group International | 1.57 Bn | 1.29 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.14 Mn |
| Dec 31, 2025 | 12.78 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Dec 31, 2023 | 15.30 Mn |